Canberra GPs are now able to prescribe medications for Attention Deficit Hyperactivity Disorder (ADHD) to eligible patients without requiring ongoing reviews from specialist physicians, a change implemented on February 15, 2026. The move, an election commitment fulfilled by the ACT Government, aims to reduce wait times and ease pressure on the territory’s healthcare system.
Under the new guidelines, general practitioners who have completed specific training can continue or initiate prescriptions for patients aged six years or older who have an existing ADHD diagnosis and are currently stable on their medication. Previously, these patients required regular specialist reviews to maintain access to their prescriptions. GPs will no longer require Chief Health Officer approval to continue prescribing.
Health Minister Rachel Stephen-Smith stated the changes are intended to address barriers to treatment faced by individuals and families affected by ADHD. “These changes around prescribing ADHD medications are the first stage of our approach to better supporting ADHD care in the ACT,” she said. The reforms are designed to reduce delays, decrease the demand for specialist appointments, and lessen administrative burdens on healthcare professionals.
The Australian Medical Association (AMA) ACT president, Dr Kerrie Aust, welcomed the changes as a “sensible reform” that aligns with clinical realities and responds to calls from patients and families for improved access to care. “Importantly, the changes maintain appropriate safeguards and recognise the role of GPs as central providers of care,” Dr Aust said. “We look forward to its implementation and evaluation, and to seeing the benefits this change brings for Canberrans who have long sought a more responsive and streamlined system.”
Although the new rules allow trained GPs to take on a greater role in managing ADHD medication, GPs who have not completed the required training will continue to operate under existing shared-care arrangements with paediatricians, psychiatrists, and neurologists.
The reforms also include a new requirement for psychiatrists, paediatricians, and neurologists to obtain Chief Health Officer approval to prescribe ADHD medications to patients within specified dosage ranges. This measure is intended to ensure consistent and safe prescribing practices across the territory.
According to the Royal Australian College of GPs (RACGP) NSW&ACT chair, Dr Rebekah Hoffman, the changes represent a significant step forward in improving access to timely treatment. “These updates will craft a tangible difference for patients and families who often face long waits for specialist appointments,” she said. “Allowing trained GPs to continue prescribing for stable patients within a clear clinical framework helps ensure people receive timely, consistent, and accessible care.”
Further changes are planned for later in 2026, with the ACT Government intending to allow GPs, following additional training, to diagnose ADHD and initiate medication for new patients. Ms Stephen-Smith indicated this expansion will further improve access to care and alleviate pressure on the health system, while maintaining safety and appropriate monitoring protocols.
